Codiak Presents New Preclinical Data Supporting Development

– Engineered exosome vaccine construct generated durable, comprehensive immunity in vivo – CAMBRIDGE, Mass., April 20, 2022 (GLOBE NEWSWIRE) -- Codiak...

Related Keywords

Cambridge , Cambridgeshire , United Kingdom , Washington , United States , Codiak Biosciences , Gaurav Gaiha , Sriram Sathyanarayanan , Ragon Institute , Codiak Biosciences Inc , World Vaccine Congress , Nasdaq , Chief Scientific Officer , Nasdaq Cdak , Nc , Vaccines , Coronavirus , Exosomes ,